Invokana May Increase Bone Fracture Risk: FDA
(MedPage Today) -- Follows evidence linking the SGLT2 inhibitor to fractures
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Canagliflozin | Cardiology | Cardiovascular | Heart | Invokana | Orthopaedics | SGLT2 Inhibitors